Enzo Therapeutics

Enzo Therapeutics is the drug development subsidiary of Enzo Biochem, Inc., a life sciences company focused on harnessing biological processes for diagnostic and therapeutic applications. The company utilizes proprietary technology platforms, including nucleic acid labeling and delivery systems, to develop treatments for inflammatory, infectious, and malignant diseases. Its lead clinical programs have historically focused on immune regulation and viral inhibition, notably through candidates like Alequel for Crohn's disease. While the parent company has recently emphasized its life sciences reagent and diagnostic business, Enzo Therapeutics maintains a portfolio of intellectual property and early-to-mid-stage candidates in the biotechnology space.